Stocks and Investing
by (remove) : Robyn Karnauskas
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Robyn Karnauskas
RSSJSONXMLCSV
Fri, July 26, 2024
Tue, June 11, 2024
Thu, May 16, 2024
Fri, April 12, 2024
Mon, April 1, 2024
Tue, March 26, 2024
Mon, March 25, 2024
Wed, March 6, 2024
Tue, February 6, 2024
Wed, January 31, 2024
Wed, November 29, 2023
Fri, November 17, 2023
Thu, November 2, 2023
Fri, October 6, 2023
Thu, October 5, 2023
Wed, October 4, 2023
Mon, September 25, 2023
Fri, September 15, 2023
Tue, September 5, 2023
Wed, August 16, 2023
Tue, August 15, 2023
Tue, August 8, 2023
Fri, June 30, 2023
Tue, May 2, 2023
Mon, February 13, 2023
Thu, February 9, 2023
Thu, January 5, 2023
Wed, November 16, 2022

Robyn Karnauskas Reiterated (ABBV) at Strong Buy with Increased Target to $210 on, Jul 26th, 2024


Published on 2024-10-28 12:48:55 - WOPRAI, Robyn Karnauskas
  Print publication without navigation


Robyn Karnauskas of Truist Securities, Reiterated "AbbVie Inc." (ABBV) at Strong Buy with Increased Target from $195 to $210 on, Jul 26th, 2024.

Robyn has made no other calls on ABBV in the last 4 months.



There are 4 other peers that have a rating on ABBV. Out of the 4 peers that are also analyzing ABBV, 0 agree with Robyn's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Robyn


  • Evan David Seigerman of "BMO Capital" Maintained at Buy with Increased Target to $214 on, Friday, July 19th, 2024
  • Terence Flynn of "Morgan Stanley" Maintained at Buy with Increased Target to $196 on, Thursday, July 11th, 2024
  • Christopher Raymond of "Piper Sandler" Maintained at Buy and Held Target at $190 on, Tuesday, July 2nd, 2024
  • Rajesh Kumar of "HSBC" Upgraded from Hold to Strong Buy and Held Target at $185 on, Wednesday, June 5th, 2024
Contributing Sources